Press Releases
Findings Show Urgent Need for More Oversight and Accountability
Washington, D.C. (September 1, 2020) —Today, the Select Subcommittee on the Coronavirus Crisis released a preliminary staff report
Reports Contradict the President’s Repeated False Statements
Washington, D.C. (August 31, 2020) — Today, Rep. James E.
Washington, D.C. (August 26, 2020) — On Tuesday, September 1, 2020, at 1:00 p.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid in-person/remote hearing with Treasury Secretary Steven T. Mnuchin on the Administration’s response to the country’s economic crisis.
Washington, D.C. (August 23, 2020) -- Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement in response to President Trump’s announcement that the Food and Drug Administration had provided emergency authorization for the use of convalescent plasma to treat coronavirus patients:
Washington, D.C. (August 14, 2020) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep.
Administration Concedes: “Recent Allegations of Wrongdoing Raise Serious Concerns”
Washington, D.C. (August 10, 2020) -- Today, Rep. James E.
Washington, D.C. (Aug. 7, 2020) — Yesterday, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.